You have 9 free searches left this month | for more free features.

City

Brisbane (1)

Chengdu (1)

Condition

Asthma (2)

Eosinophilic Granulomatosis With Polyangiitis (1)

Overall Status

Active, not recruiting (1)

Not yet recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 1 (2)

phase 2/phase 3 (1)

Sponsor

Atridia Pty Ltd. (1)

Guangdong Hengrui Pharmaceutical Co., Ltd (1)

Jiangsu HengRui Medicine Co., Ltd. (1)

Collaborator

Intervention

shr-1703 (3)

placebo (2)

shr-1703 placebo (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

shr-1703

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Eosinophilic Granulomatosis With Polyangiitis Trial (SHR-1703, SHR-1703 Placebo)

Not yet recruiting

Eosinophilic Granulomatosis With Polyangiitis

SHR-1703
SHR-1703 Placebo

(no location specified)

Jul 30, 2023

Asthma Trial in Brisbane (SHR-1703, Placebo)

Terminated

Asthma

SHR-1703
Placebo

Brisbane, Queensland, Australia

Nucleus Network

Nov 18, 2021

Asthma Trial in Chengdu (SHR-1703, Placebo)

Active, not recruiting

Asthma

SHR-1703
Placebo

Chengdu, Sichuan, China

West China Hospital of Sichuan University

Oct 25, 2021